Reyes, Jenelyn B.

HRN: 05-99-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2023
CEFTRIAXONE 1G (VIAL)
03/12/2023
03/19/2023
IV
1 Gram
Q12H
Massive Ascites Prob Sec To Malignancy
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes